aTyr Pharma, Inc. (ATYR) has a consensus analyst rating of Hold, based on 9 analysts covering the stock. Of those, 2 recommend buying, 7 recommend holding, and 0 recommend selling.
The analyst consensus price target for ATYR is $5.13, representing a +510.1% upside from the current price of $0.8409. Price targets range from a low of $1.00 to a high of $17.00.
